These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12109858)

  • 1. Clinicopathologic significance of expression of CD44s and CD44v6 isoforms in squamous cell carcinoma of the supraglottic larynx.
    Rodrigo JP; Domínguez F; Alvarez C; González MV; Herrero A; Suárez C
    Am J Clin Pathol; 2002 Jul; 118(1):67-72. PubMed ID: 12109858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of CD44v6 and nm23 protein immunoexpression in laryngeal squamous cell carcinoma.
    Sikorska B; Danilewicz M; Wagrowska-Danilewicz M
    Pol J Pathol; 2002; 53(1):17-24. PubMed ID: 12014221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
    Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
    Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer.
    Kawano T; Nakamura Y; Yanoma S; Kubota A; Furukawa M; Miyagi Y; Tsukuda M
    Auris Nasus Larynx; 2004 Mar; 31(1):35-41. PubMed ID: 15041052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.
    Diaz LK; Zhou X; Wright ET; Cristofanilli M; Smith T; Yang Y; Sneige N; Sahin A; Gilcrease MZ
    Clin Cancer Res; 2005 May; 11(9):3309-14. PubMed ID: 15867228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44s and CD44v6 expression in head and neck epithelia.
    Mack B; Gires O
    PLoS One; 2008; 3(10):e3360. PubMed ID: 18852874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma.
    Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T
    Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
    Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM
    Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
    Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD44s and CD44 splice variants in human melanoma.
    Ranuncolo SM; Ladeda V; Gorostidy S; Morandi A; Varela M; Lastiri J; Loria D; Del Aguila R; Joffé EB; Pallotta G; Puricelli L
    Oncol Rep; 2002; 9(1):51-6. PubMed ID: 11748454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of CD44s expression in biliary tract cancers.
    Lee SM; Lee KE; Chang HJ; Choi MY; Cho MS; Min SK; Lee HK; Mun YC; Nam EM; Seong CM; Lee SN
    Ann Surg Oncol; 2008 Apr; 15(4):1155-60. PubMed ID: 18214619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study.
    Morris SF; O'Hanlon DM; McLaughlin R; McHale T; Connolly GE; Given HF
    Eur J Surg Oncol; 2001 Sep; 27(6):527-31. PubMed ID: 11520083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of CD44s and CD44v6 in laryngeal squamous cell carcinoma and their significance].
    Wang SL; Yang Q; Xiao BK; Jiang YS; Chen EH
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Oct; 14(10):446-8. PubMed ID: 12563713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
    Cabanillas R; Rodrigo JP; Astudillo A; Domínguez F; Suárez C; Chiara MD
    Cancer; 2007 May; 109(9):1791-8. PubMed ID: 17380529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 and its v6 spliced variant in lung tumors: a role in histogenesis?
    Fasano M; Sabatini MT; Wieczorek R; Sidhu G; Goswami S; Jagirdar J
    Cancer; 1997 Jul; 80(1):34-41. PubMed ID: 9210706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
    Ross JS; del Rosario AD; Bui HX; Kallakury BV; Okby NT; Figge J
    Mod Pathol; 1996 Aug; 9(8):854-60. PubMed ID: 8871928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of CD44 isoform expression in thymic epithelial neoplasms.
    Sonobe S; Miyamoto H; Nobukawa B; Izumi H; Futagawa T; Ishikawa N; Yamazaki A; Uekusa T; Abe H; Suda K
    Cancer; 2005 May; 103(10):2015-22. PubMed ID: 15830350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells.
    Kuncová J; Urban M; Mandys V
    APMIS; 2007 Nov; 115(11):1194-205. PubMed ID: 18092951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
    Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
    J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.